Education Board

George M. Rodgers, III, M.D., Ph.D.

Specialty Consultant (Hematology)

Dr. George M. Rodgers is Professor of Medicine and Pathology at the University of Utah. He is also Medical Director of the Coagulation Laboratory at ARUP Laboratories. He received his M.D. and Ph.D. degrees from Tulane University, did internal medicine training at Baylor College of Medicine, and received hematology fellowship training at UCSF.

Dr. Rodgers' clinical and research interests include benign hematology, especially disorders of hemostasis and thrombosis. He has published over 170 journal articles and book chapters as well as 2 books, primarily on coagulation subjects. He is an associate editor at JNCCN and is an associate editor of Wintrobe Clinical Hematology, textbook.

CURRICULUM VITAE

George M. Rodgers, III, M.D., Ph.D.

I. PERSONAL DATA:

Name: George M. Rodgers, III, M.D., Ph.D.

Birth date: October 9, 1948

Birthplace: Shreveport, Louisiana

Citizenship: U.S.

Home Address: 4306 Zarahemla Drive

Salt Lake City, Utah 84124

Home phone (801) 272-3761

Work phone (801) 585-3229

II. EDUCATION:

1970 Louisiana State University B.S. Biochemistry

1974 Tulane University Ph.D. Pharmacology

1976 Tulane University M.D.

1976 1979 Baylor College of Medicine Internship & Residency

1976 1977 Baylor College of Medicine Instructor in Medicine

1979 1982 University of California, San Francisco Cancer Research Institute Hematology/Oncology Fellowship

III. PROFESSIONAL EXPERIENCE:

1980 - 1982 Attending Physician, Emergency Service, San Francisco General Hospital

1982 - 1983 Instructor of Medicine in Residence, University of California San Francisco and Attending Physician UCSF Hospitals and Clinics

1983 - Jun 1988 Assistant Professor of Medicine in Residence, San Francisco General Hospital and Cancer Research Institute, University of California San Francisco

1984 - 1987 Scientist, The Gladstone Foundation Laboratories for Cardio-vascular Disease

1986 - Jun 1988 Assistant Professor of Laboratory Medicine in Residence, San Francisco General Hospital

1987 - Jun 1988 Clinical Laboratory Hematologist, Department of Laboratory Medicine, San Francisco General Hospital

1988 - 1995 Associate Professor of Medicine, Division of Hematology-Oncology, University of Utah Medical Center, Salt Lake City

Sep 1989 - 1996 Adjunct Associate Professor of Pathology, University of Utah Medical Center, Salt Lake City

Jan 1990 - present Medical Director, Coagulation Laboratory, University Hospital, University of Utah Medical Center and Associated Regional & University Pathologists, Salt Lake City, Utah

Jul1990 - Jul 2003 Staff Physician, Medical Service, Veterans Administration Hospital, Salt Lake City, Utah

Jan 1991 - 2000 Faculty Member, Center for Biopolymers at Interfaces, University of Utah, Salt Lake City, Utah

Jul 1991 Tenure awarded, University of Utah Medical Center

Aug 1991 - present Co-Director, Mountain States Regional Hemophilia Center, University of Utah Medical Center

Jul 1993 - 2001 Adjunct Associate Professor of Family and Preventive Medicine, University of Utah Medical Center, Salt Lake City, Utah

Jul 1995 - Dec 1998 Professor of Medicine, Division of Hematology-Oncology, University of Utah Health Sciences Center, Salt Lake City, Utah

Jan 1997 - present Hematologist, Hereditary Hemorrhagic Telangiectasia Comprehensive Treatment Center, University of Utah Health Sciences Center, Salt Lake City, Utah

Jul 1996 - present Adjunct Professor of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah

Mar 1997 - Oct 1999 Medical Director, Anticoagulation Clinic, University of Utah Health Sciences Center, Salt Lake City, Utah

Jan 1998 - Jul 2006 Consulting Staff Physician, Division of Hematology-Oncology, Primary Children's Medical Center, Salt Lake City, Utah

Jan 1999 - present Professor of Medicine, Division of Hematology and Division of Oncology, University of Utah Health Sciences Center, Salt Lake City, Utah

Nov 1999 - present Faculty member, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah

Aug 2006 - present Staff physician, Division of Hematology-Oncology, Primary Children?s Medical Center, Salt Lake City, Utah

Dec 2007 - present Specialty consultant (hematology), University of Utah Health Care Thrombosis Service, University of Utah Health Sciences Center, Salt Lake City, Utah

IV. HONORS

Phi Kappa Phi, Louisiana State University 1970

SAMA UTMB Research Forum, Galveston, Texas, 1972

Mead Johnson Excellence in Research Award, First Place; Bay Area Heart Award First Place SAMA UTMB Research Forum, Galveston, Texas, 1974

Mead Johnson Excellence in Research Award Honorable Mention

Medical School Graduation, 1976

John T. Halsey Award Outstanding performance in Pharmacology

Louisiana Pathology Society Award Clinical pathology thesis "The Auto¬- immune Renal Disease of New Zealand Black Mice"

Dr. Frank N. Cochems 1982 Essay Prize in the field of vascular disease for the manuscript "Characterization of the Effects of Cultured Vascular Cells on the Activation of Blood Coagulation"

Irvine H. Page Arteriosclerosis Research Award for Young Investigators- Honorable Mention (Second Place), 1987 American Heart Association Council on Arteriosclerosis

Resident Teaching Award, Department of Laboratory Medicine, UCSF, 1987¬-1988

V. ADMINISTRATIVE EXPERIENCE:

Intramural

Gladstone Foundation Laboratories for Cardiovascular Disease, July 1984 - June 1987 Biosafety Committee Director, Blood Donor Screening Program

University Academic Senate Representative, University of Utah, 1990 - 1993

Member, VA Research and Development Committee, 1991-1994

Member, Division of Hematology-Oncology Fellowship Training Committee, 1991 - present

Member, Pharmacy and Therapeutics Adverse Drug Reaction Subcommittee, 1993 - present

Member, Committee to develop practice guidelines for outpatient treatment of DVT with low molecular weight heparin, 1998

Member, Second Year Curriculum Committee, 1998 - present

Member, Second Year Promotions Committee, 1998 - present

Course Director, Hematology Organ Systems Course, 1998 - 2009

Course Director, Hematology Section, MSI Curriculum, 2010 - present

Member, Medical School Admissions Committee, 1999 - 2004

Member, Laboratory Evaluation and Guideline Committee, 1999 - present

Chair, University Hospital Anticoagulation Committee, 2000

Member, Institutional Review Board, University of Utah Health Sciences Center, 2004 - 2007

Member, Tenure Advisory Committee, Department of Internal Medicine, 2004 - present

Member, University of Utah Technology Review Board, 2007 - Present

Member, Tenure Faculty Review/Clinical Faculty Review Committee, Department of Internal

Medicine, 2007 - present

Member, Intermountain Healthcare Anticoagulation Task Force, 2007 - 2009

Member, University of Utah Anticoagulation Safety Committee, 2009 - present

Extramural

Western Section Councilor for Utah, American Federation for Clinical Research, 1990 - 1995

Member, Council on Hematology, American Society of Clinical Pathologists, 1999 - 2001

Member, Hematology Resource Council, American Society of Clinical Pathologists, 2002 - present

VI. MEMBERSHIPS IN PROFESSIONAL SOCIETIES:

American Society of Hematology 1978

American Federation for Clinical Research 1980

American Heart Association 1981

Council on Thrombosis - 1981

Fellow - 1997

Western Society for Clinical Investigation 1987

International Society of Thrombosis and Haemostasis 1987

Western Association of Physicians - 1993

American Society of Clinical Pathologists - 1994

Academy of Clinical Laboratory Physicians and Scientists - 1997

North American Specialized Coagulation Laboratory Association - 1997

Chair, Subcommittee on Factor Proficiency Testing - 2005?2008

VII. CERTIFICATION EXAMINATIONS:

FLEX June 1976

National Boards Part I June 1972

Part II September, 1975

Part III December, 1976

Diplomate, American Board of Internal Medicine September, 1979 (#69461)

Diplomate, American Board of Internal Medicine, Subspecialty of Hematology - November, 1982 (#69461)

Diplomate, American Board of Pathology (Hematology) May, 1984

State Licensure Louisiana (1976 1987)

California (1978-2002)

Utah (since 1988)

VIII. GRANTS AWARDED:

(Extramural)

(a) Giannini Bank of America Foundation Research Fellowship 1981 1982

(b) National Institutes of Health (NHLBI) Clinical Investigator Award 7/1/82 6/30/87 1K08 HL01031 (Principal Investigator)

(c) National Institutes of Health (NHLBI) 12/1/83 12/1/86 R01 HL 33005 (Principal Investigator

)

(d) American Heart Association, California Affiliate 7/1/87 6/30/89 (Principal Investigator)

(e) American Heart Association, Utah Affiliate 7/1/88-6/30/89 (Principal Investigator)

(f) National Institutes of Health (NICHD) 5/1/88 4/31/90 1 P01 HD 24180 (Consultant)

(g) Veterans Administration Merit Review Award 10/1/90-9/30/93 (Principal Investigator)

(h) American Heart Association, Utah Affiliate 7/1/92-6/30/93 (Principal Investigator)

(i) American Heart Association, Utah Affiliate 7/1/93-6/30/94 (Principal Investigator)

(j) Armour Pharmaceutical Company 11/1/93-0/30/94 (Principal Investigator)

(k) Veterans Administration Merit Review Award 4/1/94 - 3/31/97 (Principal Investigator)

(l) Rhone-Poulenc Pharmaceuticals 5/1/94-6/30/95 (Principal Investigator) 4/1/95 - 6/30/96 (Contract)

(m) Armour Pharmaceuticals (Centeon) 4/1/96-3/31/97 (Principal Investigator) (Contract)

(n) Sanofi-Synthelabo 6/1/00-5/31/01 (Principal Investigator) (Contract)

(o) Organon 7/1/00-6/30/02 (Principal Investigator) (Contract)

(p) Aventis 1/1/04-12/31/04 (Principal Investigator) (Contract)

(q) Amgen 9/1/04-8/31/06 (Principal Investigator) (Contract)

(r) Alexion 9/1/06-3/30/08 (Principal Investigator) (Contract)

(s) Bayer 9/1/07-8/31/09 (Principal Investigator) (Contract)

(Intramural)

(a) Academic Senate, UCSF, 7/83 6/84

(b) American Cancer Society, University of Utah Institutional Grant, 10/88-6/89

(c) Biomedical Research Support Grant, University of Utah 4/89-3/90 > (d) Biomedical Research Support Grant, University of Utah, 4/91-3/92

(e) University Research Committee Grant, University of Utah, 6/91-5/92

(f) University Research Committee Grant, University of Utah, 1/93 - 12/93

IX. RESEARCH INTERESTS:

(a) Physiological regulation of hemostasis

(b) Procoagulant activities of vascular endothelium

(c) Role of coagulation in arteriosclerosis

(d) Antithrombotic therapy

X. CLINICAL STUDIES:

Enoxaparin Study PK529: Treatment of acute deep vein thrombosis and pulmonary embolism. Principal Investigator, University of Utah, 1993-1996.

Member, Outcome Adjudication Committee and Writing Committee.

ARG 911: An open-label study of Novastan® (argatroban) in patients with heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome, 1996.

ATLAST Enoxaparin Stent Study, Member, Data Safety Monitoring Board, 1996-1998.

Treatment of disseminated intravascular coagulation with disulfiram, 1997-1999.

An open-label trial to determine the effects of medroxyprogesterone acetate in patients with idiopathic thrombocytopenic purpura (Protocol 96-03), 1998-1999.

Organon Protocol 63-123: Treatment of pulmonary embolism with heparin vs pentasaccharide, 2000 - 2002.

Sanofi Protocol EFC 2441: Treatment of deep vein thrombosis with enoxaparin vs pentasaccharide, 2000 - 2001.

Organon Van Gogh Protocol 64714:Treatment of pulmonary embolism with idraparinux, 2003-2005.

Aventis Humate-P® Surgical Study (AP7000/1-4002), 2004.

Amgen Darbepoetin Study in Myelodysplasia, 2004 - 2006.

Alexion PNH in Bone Marrow Failure Study (EXPLORE), 2006 - 2008.

Bayer Rivaroxiban Study in Venous Thromboembolism, 2007 - 2009.

Astellas Pharma YM150 OPAL-2 Study (YM150 vs warfarin in patients with non-valvular atrial fibrillation) Steering Committee Member, 2006 - present.

XI. SYMPOSIA AND WORKSHOPS:

(a) Gordon Research Conference on Hemostasis, 1982. Invited participant, "Endothelium and Blood Coagulation."

(b) XXI Congress of the International Society of Haematology, Sydney, Australia 1986. Invited participant, "Vessel Wall and Haemostasis Symposium."

(c) American Federation for Clinical Research, Washington, D.C., 1987. Invited participant, "Endothelial Cells and Atherosclerosis Symposium."

(d) Second International Congress of Cardiology, Milan, Italy, 1989. Invited participant, "The Endothelium as an Interface of Blood Vessel Wall Interactions Symposium."

(e) Update in Cardiology: Advances in the Management of Thromboembolic Disease, A UCSF Symposium, 1990. Invited participant, "Thrombosis in Coronary Artery Disease."

(f) Utah Scientific Meeting, American College of Physicians, 1990. Invited participant, "Evaluation and Therapy of Recurrent Thrombosis: The Hypercoagulability Syndromes."

(g) American Society of Clinical Pathologists Workshop, New Orleans 1991. Workshop Director, "An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders."

(h) Symposium on Medical, Surgical and Radiologic Aspects of Treating Acute and Chronic Vascular Occlusive Disease, Salt Lake City, Utah, 1992. Invited participant, "Normal Coagulation and Disorders of Coagulation."

(i) American Society of Clinical Pathologists Workshop, Las Vegas 1992. Workshop Director, "An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders."

(j) Intermountain States Seminar, Jackson, Wyoming 1993. Invited participant, "Laboratory Monitoring of Anticoagulation."

(k) American Society of Clinical Pathologists Workshop, Seattle 1994. Workshop Director, "An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders, and Practical Aspects of Monitoring Anticoagulation."

(l) Symposium on New Developments in the Management of Common Vascular Diseases, Park City, Utah, 1995. Invited participant, "Evaluation of the Hypercoagulable Patient."

(m) American Society of Clinical Pathologists Workshop, New Orleans 1995. Workshop Director, "An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders, and Practical Aspects of Monitoring Anticoagulation."

(n) Symposium on Diagnosis and Management of Prothrombotic States, St. Louis, 1996. Invited participant, Erythrocytosis and Thrombocytosis.

(o) American Society of Clinical Pathologists Workshop, San Diego 1996. Workshop Director, An Approach to the Laboratory Evaluation of Inherited Thrombotic Disorders, and Practical Aspects of Monitoring Anticoagulation.

(p) American Association for Clinical Chemistry Workshop, Atlanta 1997. Workshop Director, Coagulation-Chemistry Interactions in the New Laboratory Environment: An Introduction to Coagulation Testing and Standardization.

(q) American Society of Clinical Pathologists Workshop, Los Angeles 1998. Workshop Director,Coagulation-Chemistry Interactions in the New Laboratory Environment: An Introduction to Coagulation Testing and Standardization.

(r) Utah Society for Clinical Laboratory Science/Clinical Laboratory Management Association. Spring Meeting, Salt Lake City 1998. Invited participant, "Laboratory Evaluation of Hypercoagulability."

(s) American Association for Clinical Chemistry Workshop, Chicago 1998. Workshop Director, "Coagulation-Chemistry Interactions in the New Laboratory Environment: An Introduction to Coagulation Testing and Standardization.

(t) American Society of Clinical Pathologists Workshop, Orlando 1999. Workshop Director, ?Coagulation-Chemistry Interactions in the New Laboratory Environment: An Introduction to Coagulation Testing and Standardization.

(u) Symposium on Bleeding Disorders in Women, Park City, Utah 1999. Moderator.

(v) American Association for Clinical Chemistry Workshop, New Orleans 1999. Workshop Director, ?An Introduction to Hemostasis and Thrombosis, Coagulation Testing and Standardization.

(w) Utah Scientific Meeting, American College of Physicians - American Society of Internal Medicine, Snowbird, Utah, 1999. Invited participant, "Initial Diagnostic Work-up of Anemia: How Far Should We? Go"

(x) Baylor-Sammons Cancer Center Third Annual Conference, Jacksonville 1999. Conference Speaker, "Outpatient Treatment of Deep-Venous Thrombosis."

(y) American Association for Clinical Chemistry Workshop, San Francisco, 2000. Workshop Director, "An Introduction to Hemostasis and Thrombosis, Coagulation Testing and Standardization".

(z) Advances in Internal Medicine, Park City, 2000. Invited participant, "Factor V Leiden and Thrombotic Disease".

(aa) Network for Oncology Communication and Research Guidelines Meeting: Clinical Thrombosis Issues in Oncology, Tucson, 2000. Invited participant, "Venous Thrombosis Treatment in the Cancer Patient".

(bb) American Society of Clinical Pathologists Workshop, San Diego, 2000. Workshop Director, "Case Studies in Hemostasis".

(cc) Roundtable Moderator, "Hypercoagulability Testing: Which Assays to Perform?", American Society of Clinical Pathologists Meeting, San Diego, 2000.

(dd) Network for Oncology Communication and Research Meeting: Challenging Cases in Hematology, San Diego, 2000. Invited participant, "Deep Vein Thrombosis Therapy."

(ee) NICHD Conference: Thrombophilia and Pregnancy Outcome, Detroit, 2000. Invited participant, "Functional Coagulation Testing in Pregnancy" and "Antithrombin III, Protein C, and Protein S Deficiency During Pregnancy."

(ff) Network for Oncology Communication and Research Meeting: Challenging Cases in Hematology, New Orleans, 2000. Invited participant, "Deep Vein Thrombosis Therapy."

(gg) Illinois Clinical Laboratory Science Association, Michigan City, Indiana, 2001. Invited participant, "Inherited Thrombosis."

(hh) Network for Oncology Communication and Research Meeting: Challenging Cases in Oncology, New Orleans, New York, Key Biscayne, and Las Vegas, 2001. Invited participant, Deep Vein Thrombosis Therapy.

(ii) American Society for Colorectal Surgeons Conference on Venous Thromboembolism in the Cancer Patient, San Diego, 2001. Invited participant, "Cancer and Hypercoagulability."

(jj) Low Molecular Weight Heparins: Emerging Concepts for Treatment and Prevention, Salt Lake City, 2001. Invited participant, Overview of Low Molecular Weight Heparins.

(kk) Advances in Internal Medicine, Deer Valley, UT, 2002. Invited participant, Case Problems in Hematology.

(ll) Hoag Cancer Center, Spring Symposium on Coagulation Issues in Cancer Patients, Newport Beach, 2002.

(mm) HHT Annual Conference, Baltimore, MD, 2002. Invited participant, Hematologic Management of HHT.

(nn) Arkansas Chapter, Clinical Laboratory Management Association, Little Rock, AR, 2002. Invited participant, Hypercoagulability.

(oo) Advances in Internal Medicine, Park City, UT, 2003. Invited participant, "Case Problems in Hematology."

(pp) Seventh Annual Winter Oncology Conference, Whistler Canada, 2003. Invited participant, "Current Status of LMWH in Thrombosis Management."

(qq) American Society of Clinical Pathologists Workshop, New Orleans, 2003. Workshop Director, "Case Studies in Hemostasis."

(rr) Antithrombotic Therapy and Update for Women's Health, Houston, 2003. Invited participant, Risks and Management of Venous Thromboembolism During Pregnancy.

(ss) Current Trends in Supportive Therapy, New York, 2003. Invited participant, Prevention of Thromboembolic Complications in Cancer Patients.

(tt) Antithrombotic Therapy Current Management Strategies, Salt Lake City, 2003. Invited participant,Heparin-Induced Thrombocytopenia.

(uu) Thromboembolic Disease, St. Joseph Mercy Oakland Clinic Day Symposium, Pontiac, Michigan, 2003. Invited participant, The Impact of Hereditary Thrombophilia in Medical Care.

(vv) American Society of Clinical Pathologists Workshop, San Antonio, 2004. Workshop Director, Case Studies in Hemostasis.

(ww) American Society of Clinical Pathologists Teleconference, 2004. Director, Case Studies in Hemostasis.

(xx) Venous Thromboembolism: New Strategies for Prevention , Diagnosis and Management, Salt Lake City, 2004. Invited participant, Thrombophilias and Their Importance for Clinical Management.

(yy) 2004 Fall Critical Care Conference, Dixie Regional Medical Center, St. George, Utah, 2004. Invited participant, Thrombocytopenia and Coagulopathy in the ICU Patient.

(zz) Pathology Grand Rounds, Portneuf Regional Medical Center, Pocatello, Idaho, 2004, Factor V Leiden: Laboratory Testing and Clinical Implications.

(aaa) American Society of Clinical Pathologists Hematology Conference, Midwestern University, Glendale, AZ, 2004. Invited participant, Case Discussions in Hemostasis.

(bbb) Network for Oncology Communication and Research Meeting: Highlights of the American Society of Hematology Meeting, San Francisco, 2005. Invited participant, Update on Coagulation.

(ccc) Louisiana-Mississippi Joint Annual Meeting of Clinical Laboratory Science, New Orleans, LA, 2005. Invited participant, Case Studies in Hemostasis.

(ddd) College of American Pathologists Annual Meeting, Chicago, 2005. Invited participant, Controversial Topics in Coagulation.

(eee) National Comprehensive Cancer Network Clinical Practice Guideline Symposium on Supportive Care, Houston and New York, 2005. Invited participant, Cancer and Chemotherapy-Related Anemia Guidelines.

(fff) Symposium on Management of Anemia and Myelodysplastic Syndromes in Hematology-Oncology Practice.American Society of Hematology meeting, Atlanta, 2005. Moderator.

(ggg) National Comprehensive Cancer Network 11th Annual Conference, Hollywood, FL, 2006. Invited participant, Update in Supportive Care-New Trends in the Treatment of Anemia.

(hhh) College of American Pathologists Annual Meeting, San Diego, 2006. Invited participant, Controversial Topics in Coagulation.

(iii) HHT Annual Conference, San Diego, 2006. Invited participant, Anemia Associated with HHT and its Management.

(jjj) Oncology Grand Rounds, University of Colorado Health Sciences Center, Denver, 2006. Venous Thromboembolism in Cancer: New Insights with Anticoagulant Therapies.

(kkk) Symposium on Catastrophic Bleeding. University of Utah Health Sciences Center, Salt Lake City, UT, 2006. Organizer and moderator.

(lll) Utah Valley Symposium on Venous Thromboembolic Disease, Provo, 2007. Invited participant, Heparin-induced Thrombocytopenia.

(mmm) Hawaii ASCLS/CLMA Annual Meeting, Honolulu, 2007. Invited participant, Thrombophilia Testing?Useful or Not?? and Case Studies in Hemostasis.

(nnn) Illinois-Indiana-Kentucky CLMA Meeting, Madisonville, KY, 2007. Invited participant, Thrombophilia Testing-Useful or Not

(ooo) College of American Pathologists Annual Meeting, Chicago, IL, 2007. Invited participant,Controversial Topics in Coagulation.

(ppp) American Society of Clinical Pathologists Teleconference, 2007. Director, Case Studies in Hemostasis.

(qqq) National Alliance for Thrombosis and Thrombophilia Symposium, Salt Lake City, 2007. Invited participant, "Risk Factors for Blood Clots" "Inherited and Acquired Clotting Disorders (Thrombophilias)," and "Prevention of Clots for Those at Risk."

(rrr) University Healthcare Thrombosis Symposium, Salt Lake City, UT, 2008. Invited participant, "Managing Complications of Anticoagulant Therapy: Heparin" "Induced Thrombocytopenia" and "The Acutely Bleeding Patient."

(sss) American Society of Clinical Oncology, Chicago, IL, 2008. Chair, Symposium on "Clinical Controversies in the Treatment of Anemia: Appropriate Use of Erythropoietic Stimulating Agents in a Time of Change."

(ttt) College of American Pathologists Annual Meeting, San Diego, CA, 2008. Workshop Director, "Controversial Topics in Coagulation."

(uuu) University of Tennessee, Department of Medicine Grand Rounds, Chattanooga, TN, 2008. Invited participant, "Managing Anemia in Oncology Settings: The Role of Intravenous Iron Therapy."

(vvv) Advances in Internal Medicine, Park City, UT, 2009. Invited participant, Transfusion Medicine - 2009.

(www) Idaho Society?ASCLS Annual Meeting, Boise, ID, 2009. Invited participant, "Case Studies in Hemostasis."

(xxx) College of American Pathologists Annual Meeting, Washington, DC, 2009. Workshop Director, "Controversial Topics in Coagulation."

(yyy) Utah Chapter, American College of Physicians Annual Meeting, Salt Lake City, UT, 2009. Invited participant, "Chronic Leukemia and Chronic Anemia."

(zzz) Rush University Medical Center, Department of Pediatrics Grand Rounds, Chicago, IL, 2010. Invited participant, "Immune-Mediated Coagulopathy in the Post-Operative Setting."

(aaaa) Western Regional Thrombosis Symposium, Salt Lake City, UT, 2010. Invited participant, "Management of Venous Thromboembolism in the Cancer Patient."

(bbbb) Advances in Internal Medicine, Park City, UT, 2011. Invited participant, "Hematologic Emergencies for the Internist."

(cccc) Huntsman Cancer Institute Annual Hematology Review, Salt Lake City, UT, 2011. Invited participant, "Update on Coagulation."

(dddd) Western Regional Thrombosis Symposium, Salt Lake City, UT, 2012. Invited participant, "VTE in the Cancer Patient/Update on Heparin-Induced Thrombocytopenia."

XII. EDITORIAL RESPONSIBILITIES:

(

a) Editorial Boards

Journal of the National Comprehensive Cancer Network (JNCCN), 2005 - present

American Journal of Clinical Pathology, 1994-2002

Section Editor for Coagulation, Jan 2000-2002

American Society of Clinical Pathologists, Check-Sample Section Editor (Clinical Laboratory Hematology) 1994-2001

Thrombosis Research, 1995-1998

(b) Reviewer - Journals

Blood

Circulation

Arteriosclerosis and Thrombosis

American Journal of Hematology

Journal of Thrombosis and Haemostasis

Obstetrics & Gynecology

Blood Coagulation and Fibrinolysis

(c) Granting Agencies

VA Merit Review - Hematology Subcommittee, Ad Hoc Member, October 1999

(d) Textbooks

Associate Editor (Hemostasis) - WINTROBE'S CLINICAL HEMATOLOGY (10th edition), 1998

Associate Editor (Hemostasis) - WINTROBE'S CLINICAL HEMATOLOGY (11th edition), 2003

Associate Editor (Hemostasis) - WINTROBE'S CLINCAL HEMATOLOGY (12th edition), 2009

(e) Consensus Conference - College of American Pathologists Conference on Inherited Thrombosis, 2001.

(f) National Comprehensive Cancer Network, Consensus Panel on Anemia, 2001 - present

Chair, Panel on Anemia, 2004 - present.

(g) American Society of Clinical Pathologists Teleconference Committee (Hematology and Coagulation), 2008 - present.

XIII. TRAINEES SUPERVISED:

Hematology-Oncology Fellows:

Dr. John R. Weis (July 1989 - June 1991)

Dr. Kelly J. Faucette (July 1990 - June 1992)

Dr. Alan Grosset (October 1992 - February 1996)

Dr. Joseph Spahr (April 2005 - June 2007)

Dr. Justin Thomas (July 2010 - Present)

Dr. Marc Nuttal (July 2011 - Present)

Thesis committees:

Chih-Hu Ho, Ph.D. (August 1995, Materials Science and Engineering)

Bing Leng, Ph.D. (October 2007, Bioengineering)

Mohamed Jama, M.S. (March 2009, Laboratory Medicine and Biomedical Science)

Visiting scientists:

Lihua Liu, M.D. (West China University of Medical Sciences) May 1992 - October 1997

Carolyn L. Orthner, Ph.D. (American Red Cross Research Laboratories, Rockville, MD) January - July, 1994

Pathology residents:

Scott R. Florell, M.D. (January 1994 - June 1997)

Brian E. Staley, M.D. (November 1997 - December 1998)

David T. Yang, M.D. (January 2004 - August 2006)

Medicine residents:

Melissa Bentley, M.D. (August 2007 - 2010)

Students:

Brent D. Wilson (December 1989 - June 1992), Honors thesis

David B. Gubler (January 1992 - June 1995)

Richard H. Fryer (June 1992 - June 1995)

Chad R. Ahlstrom (October 1993 - June 1995), Honors thesis

Matthew H. Johnson (September 1995 - September 1996)

Pete M. Cliften (October 1996 - April 1997)

Andrew G. Drollinger (June 1996 - June 1998)

Eric N. Rasmussen (April 1998 - December 1998)

Usha R. Thekkedath (November 1998 - 2003)

Todd A. Nelson (May 2002 - August 2003)

Casey Lythgoe (Summer 2003)

Ben F. Johnson (September 2003 - October 2004)

Cameron T. Warnick (January 2005 - June 2005)

Keith B. Warner (May 2005 - May 2007)

Cambria A. Judd (May 2006 - May 2008)

Justin K. Smith (February 2008 - June 2010)

Jes?ica Stengel (June 2008 - January 2009)

Patrick Warr (August 2009 - May 2010)

Jonathan R. Baza (August 2010 - Present)

PUBLICATIONS

THESIS: Rodgers, George M.: The Role of Adenosine 3', 5'-Monophosphate in Erythropoiesis. Tulane University, 1974.

1. Rodgers, George M., George, William, J., and Fisher, James W.: Increased Kidney Cyclic AMP Levels and Erythropoietin Production Following Cobalt Administration. Proc. Soc. Exp. Biol. Med. 140:977 981, 1972.

2. Rodgers, George M., Fisher, James W., and George, William J.: Activation of the Renal Erythropoietic Factor by a Cyclic AMP Dependent Protein Kinase. Proc. Soc. Exp. Biol. Med. 145:1207 1211, 1974.

3. Rodgers, George M., Fisher, James W., and George, William J.: Elevation of Renal Cyclic GMP Concentrations and Plasma Lysosomal Enzyme Activity Following Cobalt Treatment in Rats. Biochem. Biophys. Res. Comm. 59:979 984, 1974.

4. Rodgers, George M., Fisher, James W., and George, William J.: Lactate Stimulation of Renal Cortical Adenylate Cyclase: A Mechanism for Erythropoietin Production Following Cobalt Treatment or Hypoxia. J. Pharmacol. Exp. Ther. 190:542 550, 1974.

5. Rodgers, George M., Fisher, James W., and George, William J.: The Role of Renal Adenosine 3',5' Monophosphate in Erythropoietin Production. Amer. J. Med. 58:31 38, 1975.

6. Rodgers, George M., Fisher, James W., and George, William J.: Increase in Hematocrit, Hemoglobin and Red Cell Mass in Normal Mice After Treatment with Cyclic AMP. Proc. Soc. Exp. Biol. Med. 148:380 382, 1975.

7. Fisher, James W., Busuttil, Ronald W., Rodgers, George M., Mujovic, Vujadin M., Paulo, Luiz G., Fink, Gregory D., and George, William J.: The Kidney and Erythropoietin Production. In ERYTHROPOIESIS. Proceedings of the Fourth International Conference on Erythropoiesis. (K. Nakao, J.W. Fisher and F. Takaku, editors), University of Tokyo Press, 1975, pp. 315 336.

8. George, William J., Rodgers, George M., Briggs, Daniel W., and Fisher, James W.: Role of Cyclic AMP in the Regulation of Erythropoietin Production. In ERYTHROPOIESIS. Proceedings of the Fourth International Conference on Erythropoiesis. (K. Nakao, J.W. Fisher and F. Takaku, editors), University of Tokyo Press, 1975, pp. 277 294.

9. Rodgers, George M., Fisher, James W., and George, William J.: Renal Cyclic AMP Accumulation and Adenylate Cyclase Stimulation by Erythropoietic Agents. Amer. J. Physiol. 229:1387 1392, 1975.

10. Rodgers, George M., Fisher, James W., and George, William, J.: Renal Cyclic GMP and Cholinergic Mechanisms in Erythropoietin Production. Life Sci. 17:1807 1814, 1975.

11. Rodgers, George M., Fisher, James W., and George, William J.: Elevated Cyclic GMP Concentrations in Rabbit Bone Marrow Culture and Mouse Spleen Following Erythropoietic Stimulation. Biochem. Biophys. Res. Comm. 70:287 294, 1976.

12. Fink, Gregory D., Paddock, Richard J., Rodgers, George M., and George, William J.: Elevated Cyclic GMP Levels in Rabbit Atria Following Vagal Stimulation and Acetylcholine Treatment. Proc. Soc. Exp. Biol. Med. 153:78 82, 1976.

13. George, William J. and Rodgers, George M.: Cyclic Nucleotides and the Regulation of Erythropoiesis. In KIDNEY HORMONES, Vol. II (Fisher, James W., ed.). Academic Press, New York, 1977, pp. 329 356.

14. George, William J., Briggs, Daniel W., Rodgers, George M., and Fisher, James W.: Metabolism of Erythropoietin. In KIDNEY HORMONES, Vol. II (Fisher, James W., ed.). Academic Press, New York, 1977, pp. 73 109.

15. George, William J., Rodgers, George M., and White, LuAnn: Cyclic Nucleotides as Regulators of Erythrocyte Proliferation. In ADVANCES IN CYCLIC NUCLEOTIDE RESEARCH, Vol. 9 (George, W.J. and Ignarro, L.J., eds.). Raven Press, New York, 1978, pp. 517 532.

16. Fisher, James W., Gross, Dennis M., Foley, James E., Nelson, Peter K., Rodgers, George M., George, William J., and Jubiz, William: A Concept for the Control of Kidney Production of Erythropoietin Involving Prostaglandins and Cyclic Nucleotides. Contr. Nephrol. 13:37 59, 1978.

17. Rodgers, George M., Barrera, Ermilio, and Martin, R. Russell: Bacillus Cereus Bacteremia and Hemolytic Anemia in a Patient with Hemoglobin SC Disease. Arch. Int. Med. 140:1103 1104, 1980.

18. Rodgers, George M., Carrera, Carlos J., Ries, Curt A., and Bainton, Dorothy F.: Blastic Transformation of a Well Differentiated Monocytic Leukemia: Changes in Cytochemical and Cell Surface Markers. Leuk. Res. 6:613 622, 1982.

19. Rodgers, George M. and Shuman, Marc A.: Acquired Cyclic Neutropenia: Successful Therapy with Prednisone. Amer. J. Hematol. 13:83 89, 1982.

20. Rodgers, George M., Donaldson, Virginia H., and Shuman, Marc A.: Radioisotopic Measurement of Plasma Kallikrein. Thrombosis Res. 27:641 649, 1982.

21. Rodgers, George M., Greenberg, Charles S., and Shuman, Marc A.: Characterization of the Effects of Cultured Vascular Cells on the Activation of Blood Coagulation. Blood 61:1155 1162, 1983.

22. Rodgers, George M. and Shuman, Marc A.: Prothrombin is Activated on Vascular Endothelial Cells by Factor Xa and Calcium. Proc. Natl. Acad. Sci. USA. 80:7001 7005, 1983.

23. Rodgers, George M., Broze, George J., and Shuman, Marc A.: The Number of Receptors for Factor VII Correlates with the Ability of Cultured Cells to Initiate Coagulation. Blood 63:434 438, 1984.

24. Drake, Thomas A., Rodgers, George M., and Sande, Merle A.: Tissue Factor is a Major Stimulus for Fibrin Deposition in Vegetations of Enterococcal Endocarditis in the Rabbit. J. Clin. Invest. 73:1750 1753, 1984.

25. Rodgers, George M. and Shuman, Marc A.: Characterization of the Interaction Between Factor Xa and Bovine Aortic Endothelial Cells. Biochim. Biophys. Acta. 844:320 329, 1985.

26. Rodgers, George M. and Corash, Laurence: Acquired Heparin like Anticoagulant in a Patient with Metastatic Breast Carcinoma. West. J. Med. 143:672 675, 1985.

27. Rodgers, George M. and Shuman, Marc A.: Congenital Thrombotic Disorders. Amer. J. Hematol. 21:419 430, 1986.

28. Rodgers, George M. and Kane, William H.: Activation of Endogenous Factor V by a Homocysteine Induced Vascular Endothelial Cell Activator. J. Clin. Invest. 77:1909 1916, 1986.

29. Bloom, Elana J., Abrams, Donald I., and Rodgers, George M.: Lupus Anti-coagulant in the Acquired Immunodeficiency Syndrome. J. Amer. Med. Assoc. 256:491 493, 1986.

30. Rodgers, George M. and Shuman, Marc A.: Enhancement of Prothrombin Activation on Platelets by Endothelial Cells and Mechanism of Activation of Factor V. Thrombosis Res. 45:145 152, 1987.

31. Rodgers, George M., Cong, Jingyang, Goll, Darrel E., and Kane, William H.: Activation of Coagulation Factor V by the Calcium Dependent Proteinase. Biochim. Biophys. Acta. 929:263 270, 1987.

32. Rodgers, George M.: Vascular Smooth Muscle Cells Synthesize, Secrete, and Express Coagulation Factor V. Biochim. Biophys. Acta. 968:17 23, 1988.

33. Rodgers, George M.: Hemostatic Properties of Normal and Perturbed Vascular Cells. FASEB Journal. 2:116 123, 1988.

34. Rodgers, George M., Kane, William H. and Pitas, Robert E.: Formation of Factor Va by Atherosclerotic Rabbit Aorta Mediates Factor Xa Catalyzed Prothrombin Activation. J. Clin. Invest. 81:1911 1919, 1988.

35. Stricker, Raphael B., Lane, Philip K., Leffert, Jonathan D., Rodgers, George M., Shuman, Marc A., and Corash, Laurence: Development of Anti Thrombin Antibodies Following Surgery in Patients with Prosthetic Cardiac Valves. Blood 72:1375-1380, 1988.

36. Perkocha, Luke A. and Rodgers, George M.: Hematologic Aspects of Human Immunodeficiency Virus Infection: Laboratory and Clinical Considerations. Amer. J. Hematol. 29:94-105, 1988.

37. Rodgers, George M., Taylor, Robert N., and Roberts, James M.: The Pregnancy Disorder, Preeclampsia, is Associated with a Serum Factor Which Damages Human Endothelial Cells. Am. J. Obstet. Gynecol. 159:908-914, 1988.

38. Musci, Thomas J., Roberts, James M., Rodgers George M., and Taylor, Robert N.: Mitogenic Activity is Increased in the Sera of Preeclamptic Women Prior to Delivery. Am. J. Obstet. Gynecol. 159:1446-1451, 1988.

39. Hirsh, Jack, Rodgers, George M., and Rubin, Ronald N.: Anticoagulants: are you up-to-date? Patient Care 22:43-61, 1988.

40. Roizen, Michael F., Rodgers, George M., Valone, Frank H., Smith, John S., Lampe, George H., Benefiel, David J., Gelman, Simon, Rapp, Joseph, Weiler, John M., Ota, Maile, Shuman, Marc A., and Goetzl, Edward J.: Anaphylactoid Reactions to Vascular Graft Material Presenting with Vasodilation and Subsequent Disseminated Intravascular Coagulation. Anesthesiology 71:331-338, 1989.

41. Hubel, Carl A., Roberts, James M., Taylor, Robert N., Musci, Thomas J., Rodgers, George M., and McLaughlin, Margaret K.: Lipid Peroxidation in Pregnancy: New Perspectives on Preeclampsia. Am. J. Obstet. Gynecol. 161:1025-1034, 1989.

42. Roberts, James M., Taylor, Robert N., Musci, Thomas J., Rodgers, George M., Hubel, Carl A., and McLaughlin, Margaret K.: Preeclampsia: An Endothelial Cell Disorder. Am. J. Obstet. Gynecol. 161:1200-1204, 1989.

43. Rodgers, George M. and Conn, Marion T.: Homocysteine, an Atherogenic Stimulus, Reduces Protein C Activation by Arterial and Venous Endothelial Cells. Blood 75:895-901, 1990.

44. Rodgers, George M.: Common Clinical Bleeding Disorders. In CONTEMPORARY MANAGEMENT IN INTERNAL MEDICINE - UPDATE ON HEMOSTASIS (Stein, Jay H., Ed.). vol. 1, number 2. Churchill Livingstone, New York, 1990, pp. 75-120.

45. Marshall, Bruce C., Brown, Brent R., Rothstein, Mark, Rao, N.V., Hoidal, John R., and Rodgers, George M.: Alveolar Epithelial Cells Express Both Plasminogen Activator and Tissue Factor: Potential Role in Repair of Lung Injury. Chest 99(Suppl):25S-27S, 1991.

46. Weis, John R., Sun, Boling, and Rodgers, George M.: Improved Method of Human Umbilical Arterial Endothelial Cell Culture. Thrombosis Res. 61:171-173, 1991.

47. Weis, John R., Whatley, Ralph E., Glenn, James L., and Rodgers, George M.: Prolonged Hypofibrinogenemia and Protein C Activation after Envenomation by the Exotic Snake, Echis carinatus. Am. J. Tropical Med. and Hygiene 44:452-460, 1991.

48. Weis, John R., Pitas, Robert E., Wilson, Brent D., and Rodgers, George M.: Oxidized Low-Density Lipoprotein Increases Human Endothelial Cell Tissue Factor Activity and Reduces Protein C Activation. FASEB Journal 5:2459-2465, 1991.

49. Taylor, Robert N., Musci, Thomas J., Rodgers, George M., and Roberts, James M.: Pre-eclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am. J. Reprod. Immunol. 25:105-108, 1991.

50. Wilson, Brent D., Pitas, Robert E., and Rodgers, George M.: Regulation of Vascular Endothelial Cell Protein C Activation by Native and Oxidized Low-Density Lipoproteins. Sem. Thromb. Hemost. 18:11-17, 1992.

51. Birchfield, George R., Rodgers, George M., Girodias, Kenneth W., Ward, John H., and Samlowski, Wolfram E.: Hypoprothrombinemia Associated with Interleukin-2 Therapy: Correction with Vitamin K. J. Immunotherapy 11:71-75, 1992.

52. Martin, Barbara A., Branch, D. Ware, and Rodgers, George M.: The Preparation of a Sensitive Partial Thromboplastin Reagent from Bovine Brain. Blood Coag. Fibrinolysis 3:287-294, 1992.

53. Kapoor, Rohit and Rodgers, George M.: Platelet Dysfunction in a Patient with the Opitz (BBBG) Syndrome. Am. J. Med. Genetics 43:796-798, 1992.

54. Faucette, Kelly J., Parker, Charles J., McCluskey, Teri, Bernshaw, Nicol J., and Rodgers, George M.: Induction of Tissue Factor Activity in Endothelial Cells and Monocytes by a Modified Form of Albumin Present in Normal Human Plasma. Blood 79:2888-2895, 1992.

55. Greenberg, Peter L., Negrin, Robert, and Rodgers, George M.: Hematologic Disorders (Chapter 22). In CLINICAL PHARMACOLOGY: BASIC PRINCIPLES IN THERAPEUTICS (Melmon, Kenneth L., Morrelli, Howard F., Hoffman, Brian B. and Nierenberg, David W., eds.). 3rd edition. McGraw-Hill, New York, pp. 524-599, 1992.

56. Rodgers, George M., and Chandler, Wayne L.: Laboratory and Clinical Aspects of Inherited Thrombotic Disorders. Am. J. Hematol. 41:113-122, 1992.

57. Hirsh, Jack, Rodgers, George M., and Rubin, Ronald N.: Fine-tuning anticoagulant therapy. Patient Care 26:69-87, 1992.

58. Rodgers, George M. and Garr, Susan B.: Comparison of Functional and Antigenic Fibrinogen Values From a Normal Population. Thrombosis Res. 68:207-210, 1992.

59. Branch, D. Ware and Rodgers, George M.: Induction of Tissue Factor Activity by Sera from Patients with Antiphospholipid Syndrome: A Possible Mechanism of Thrombosis. Am. J. Obstet. Gynecol. 168:206-210, 1993.

60. Rodgers, George M.: Epitome-Laboratory Evaluation of Inherited Thrombotic Disorders. Western J. Med. 158:297, 1993.

61. Gubler, David B., Wilson, Brent D., Parker, Charles J., and Rodgers, George M.: Regulation of Endothelial Cell Protein C Activation and Fibrinolysis by Procoagulant Albumin. Thrombosis Res. 70:459-469, 1993.

62. Fryer, Richard H., Wilson, Brent D., Gubler, D. B., Fitzgerald, Laurence A., and Rodgers, George M.: Homocysteine, A Risk Factor For Premature Vascular Disease and Thrombosis, Induces Tissue Factor Activity in Endothelial Cells. Arteriosclerosis and Thrombosis 13:1327-1333, 1993.

63. Rees, Matthew M. and Rodgers, George M.: Homocysteinemia: Association of a Metabolic Disorder with Vascular Disease and Thrombosis. Thrombosis Res. 71:337-359, 1993.

64. Faucette, Kelly J., Fitzgerald, Laurence A., Liu, Lihua, Parker, Charles J., and Rodgers, George M.: Characterization of the Interactions Between Procoagulant Albumin and Human Endothelial Cells. Blood 82:2684-2692, 1993.

65. Rodgers, George M.: Novel Antithrombotic Therapy (University of Utah Medical Grand Rounds). Western J. Med. 159:670-674, 1993.

66. Garr, Susan B. and Rodgers, George M.: Laboratory Monitoring of Warfarin Therapy in Utah. Am. J. Hematol. 45:85-87, 1994.

67. Grosset, Alan B., Allen, Jill E., and Rodgers, George M.: Anticoagulation with Anisindione in Patients who are Intolerant of Warfarin. Am. J. Hematol. 46:138-140, 1994.

68. Grosset, Alan B., Liu, Lihua, Parker, Charles J., and Rodgers, George M.: Bioassay of Procoagulant Albumin in Human Plasma. Thrombosis Res. 75:551-558, 1994.

69. MacDonald, Joel D., Remington, Benjamin J., and Rodgers, George M.: The Skin Bleeding Time as a Predictor of Brain Bleeding Time in a Rat Model. Thrombosis Res. 76:535-540, 1994.

70. Rodgers, George M.: Hematologic Aspects of Human Immunodeficiency Virus Infection (Chapter 18). In MANUAL OF CLINICAL HEMATOLOGY (Mazza, Joseph J., Ed.) 2nd edition. Little, Brown and Company, Boston, pp. 402-407, 1995.

71. Rodgers, George M.: Activated Protein C Resistance and Inherited Thrombosis (Editorial). Am. J. Clin. Pathol. 103:261-262, 1995.

72. Orthner, Carolyn L., Rodgers, George M., and Fitzgerald, Laurence A.: Pyrrolidine Dithiocarbamate Abrogates Tissue Factor Expression by Endothelial Cells: Evidence Implicating Nuclear Factor-?B in Tissue Factor Induction by Diverse Agonists. Blood 86:436-443, 1995.

73. Rodgers, George M.: Bleeding Disorders, Thrombotic Disorders, and Anticoagulant Therapy. Chapters 40-48. In PRACTICAL DIAGNOSIS OF HEMATOLOGIC DISORDERS (Kjeldsberg, C., Foucar, K., McKenna, R., Perkins, S., Peterson, L., Peterson, P., and Rodgers, G., Eds.) ASCP Press, Second edition, Chicago. pp. 625-755, 1995.

74. Gubler, David B., Ahlstrom, Chad R., Liu, Lihua, Parker, Charles J., and Rodgers, George M. Procoagulant Albumin Increases Vascular Endothelial Cell Prostacyclin Secretion. Thrombosis Haemost. 74:1573-1577, 1995.

75. Martin, Barbara A., Branch, D. Ware, and Rodgers, George M.: Sensitivity of the Activated Partial Thromboplastin Time, the Dilute Russell's Viper Venom Time, and the Kaolin Clotting Time for the Detection of the Lupus Anticoagulant: A Direct Comparison Using Plasma Dilutions. Blood Coag. Fibrinolysis 7:31-38, 1996.

76. Florell, Scott R. and Rodgers, George M.: Utilization of Testing for Activated Protein C Resistance in a Reference Laboratory. Am. J. Clin. Pathol. 106:248-252, 1996.

77. Martin, Carolyn, Varner, Michael W., Branch, D. Ware, Rodgers, George M., and Mitchell, Murray D.: Dose-Related Effects of Low Dose Aspirin on Hemostasis Parameters and Prostacyclin/Thromboxane Ratios in Late Pregnancy. Prostaglandins 51:321-330, 1996.

78. Liu, Lihua and Rodgers, George M.: Characterization of an Inducible Endothelial Cell Prothrombin Activator. Blood 88:2989-2994, 1996.

79. Florell, Scott R., and Rodgers, George M.: The PT and the Pendulum (Editorial). Am. J. Clin. Pathol. 106:699-700, 1996.

80. Florell, Scott R., and Rodgers, George M.: Inherited Thrombotic Disorders: An Update. Am. J. Hematol. 54:53-60, 1997.

81. Liu, Lihua, Murray, Darrell K., Dameron, Charles T., Parker, Charles J., and Rodgers, George M.: Biochemical Characterization of Procoagulant Albumin. Thrombosis Res. 85:399-411, 1997.

82. Fryer, Richard H., Schwobe, Eric P., Woods, Marion L., and Rodgers, George M.: Chlamydia Species Infect Human Vascular Endothelial Cells and Induce Procoagulant Activity. J. Invest. Med. 45:168-174, 1997.

83. Rodgers, George M.: The Clinical Laboratory Evaluation of Hypercoagulability. In MOLECULAR MECHANISMS OF HYPERCOAGULABLE STATES (Schafer, A.I., Ed.) R.G. Landes Bioscience, Austin, TX. pp. 165-179, 1997.

84. Grosset, Alan B., Spiro, Theodore E., Beynon, Julia, and Rodgers, George M.: Enoxaparin, a Low-Molecular Weight Heparin Suppresses Prothrombin Activation More Effectively than Unfractionated Heparin in Patients Treated for Venous Thromboembolism. Thrombosis Res. 86:349-354, 1997.

85. Carey, Michael J., and Rodgers, George M.: Disseminated Intravascular Coagulation: Clinical and Laboratory Aspects. Am. J. Hematol. 59:65-73, 1998.

86. Rodgers, George M.: Endothelium and the Regulation of Hemostasis (Chapter 25). In WINTROBE'S CLINICAL HEMATOLOGY (Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers, GM, Eds.) Williams and Wilkins, Baltimore, 10th edition, 1998, pp. 765-773.

87. Rodgers, George M. and Bithell, Thomas C.: The Diagnostic Approach to the Bleeding Disorders (Chapter 60). In WINTROBE'S CLINICAL HEMATOLOGY (Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers, GM, Eds.) Williams and Wilkins, Baltimore, 10th edition, 1998, pp. 1557-1578.

88. Rees, Matthew M. and Rodgers, George M.: Bleeding Disorders Caused by Vascular Abnormalities (Chapter 65). In WINTROBE'S CLINICAL HEMATOLOGY (Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers, GM, Eds.) Williams and Wilkins, Baltimore, 10th edition, 1998, pp. 1633-1647.

89. Rodgers, George M. and Greenberg, Charles S.: Inherited Coagulation Disorders (Chapter 68). In WINTROBE'S CLINICAL HEMATOLOGY (Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers, GM, Eds.) Williams and Wilkins, Baltimore, 10th edition, 1998, pp. 1682-1732.

90. Grosset, Alan B.M. and Rodgers, George M.: Acquired Coagulation Disorders (Chapter 69). In WINTROBE'S CLINICAL HEMATOLOGY (Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers, GM, Eds.) Williams and Wilkins, Baltimore, 10th edition, 1998, pp. 1733-1780.

91. Rodgers, George M.: Thrombosis and Antithrombotic Therapy (Chapter 70). In WINTROBE'S CLINICAL HEMATOLOGY (Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers, GM, Eds.) Williams and Wilkins, Baltimore, 10th edition, 1998, pp. 1781-1818.

92. Florell, Scott R., and Rodgers, George M.: Factor V Leiden: Death and DNA (Editorial). Am. J. Clin. Pathol. 111:302-303, 1999.

93. Rodgers, George M.: Overview of Platelet Physiology and Laboratory Evaluation of Platelet Function. SYMPOSIUM ON PLATELET DISORDERS IN PREGNANCY, In CLINICAL OBSTETRICS AND GYNECOLOGY (Silver, R.M., Ed.), vol. 42, Lippincott Raven, Philadelphia, 1999, pp. 349-359.

94. Drollinger, Andrew G., Netser, Julie C., and Rodgers, George M.: Dithiocarbamates Ameliorate the Effects of Endotoxin in a Rabbit Model of Disseminated Intravascular Coagulation. Sem. Thromb. Hemost. 25:429-433, 1999.

95. Grosset, Alan B. McGregor, John R., Samlowski, Wolfram E., and Rodgers, George M.: Immunosuppressive Properties of Factor IX Products: An In Vitro Study. Haemophilia 5:416-425, 1999.

96. Hussong, Jerry W., Rodgers, George M., and Shami, Paul J.: Evidence of Increased Angiogenesis in Patients with Acute Myeloid Leukemia. Blood 95:309-313, 2000.

97. Rodgers, George M.: Bleeding Disorders, Thrombotic Disorders, and Anticoagulant Therapy. Chapters 39-47. In PRACTICAL DIAGNOSIS OF HEMATOLOGIC DISORDERS (Kjeldsberg, C., Elenitoba-Johnson, K., Foucar, K., Hussong, J., McKenna, R. Perkins, S., Peterson, L., Peterson, P., and Rodgers, G., Eds.) ASCP Press, Third edition, Chicago, 2000.

98. Rodgers, George M.: CASE STUDIES IN HEMOSTASIS: LABORATORY DIAGNOSIS AND MANAGEMENT. ASCP Press, Chicago, 2000.

99. Gilbert, Kristine B. and Rodgers, George M.: Utilization and Outcomes of Enoxaparin Treatment for Deep-Vein Thrombosis in a Tertiary Care Hospital. Am J Hematol 65:285-288, 2000.

100. Yu, Margaret K. and Rodgers, George M.: Detection of Occult Cobalamin Deficiency with Magnetic Resonance Imaging. Am J Hematol 65:83-84, 2000.

101. Chandramouli, Nitin B. and Rodgers, George M.: Prolonged Immunoglobulin and Platelet Infusion for Treatment of Immune Thrombocytopenia. Am J Hematol 65:85-86, 2000.

102. The Enoxaparin Clinical Trial Group: Writing Committee Members: Merli, Geno, Spiro, Theodore E., Olsson, Carl G., Abildgaard, U., Davidson, Bruce L., Eldor, Amiram, Elias, Darlene, Grigg, Andrew, Musset, Dominique, Rodgers, George M., Trowbridge, Arthur A., Yusen, Roger D., and Zawilska, Krystyna: Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease. Ann Intern Med 134:191-202, 2001.

103. Lehman, Christopher M. and Rodgers, George M.: To IRB, or Not to IRB - That Is No Longer the Question. Am J Clin Pathol 115:187-191, 2001.

104. Martin, Mitchell D. and Rodgers, George M.: Hematologic and Neoplastic Aspects of Human Immunodeficiency Virus Infection. In MANUAL OF CLINICAL HEMATOLOGY (Mazza, Joseph J., Ed.), 3rd edition. Little, Brown and Company, Boston. 2001, pp. 389-398.

105. Chandramouli, Nitin B. and Rodgers, George M.: The Management of Thrombosis in Women with the Antiphospholipid Antibody Syndrome. SYMPOSIUM ON ANTIPHOSPHOLIPID ANTIBODIES AND REPRODUCTIVE PROBLEMS (Branch, D.W., Ed.), vol. 44, Lippincott, Williams & Wilkins, Philadelphia, 2001, pp. 36-47.

106. Busby, Leslie T., Weyman, Anne, and Rodgers, George M.: Excessive Anticoagulation in Patients with Mild Renal Insufficiency Receiving Long-Term Therapeutic Enoxaparin. Am J Hematol 67:54-56, 2001.

107. Fausett, M. Bardett, Vogtlander, M., Lee, R.M., Esplin, Michael S., Branch, D. Ware, Rodgers, George M., and Silver, Robert M.: Heparin-Induced Thrombocytopenia is Rare in Pregnancy. Am J Obstet Gynecol 185:148-152, 2001.

108. Lehman, Christopher M., Blaylock, Robert C., Alexander, Donald P., and Rodgers, George M.: Discontinuation of the Bleeding Time Test Without Detectable Adverse Clinical Impact. Clin Chem 47:1204-1211, 2001.

109. Robetorye, Ryan S. and Rodgers, George M.: Update on Inherited Thrombotic Disorders. Am J Hematol 68:256-268, 2001.

110. Sabbatini, Paul, Cella, David, Chanan-Khan, Asher, Cleeland, Charles, Coccia, Peter F., Demetri, George D., Djulbegovic, Benjamin, Kraut, Eric H., Millenson, Michael, Mock, Victoria, Rodgers, George and Wade, James C.: Cancer and Treatment-Related Anemia. National Comprehensive Cancer Network. Practice Guidelines in Oncology Monograph, 2001.

111. Flanders, Michele M., Crist, Ronda, Safapour Sekineh, and Rodgers, George M.: Evaluation and Performance Characteristics of the STA-R Coagulation Analyzer. Clin Chem 48:1622-1624, 2002.

112. Chandler, Wayne L., Rodgers, George M., Sprouse J., and Thompson, Arthur R.: Elevated Hemostatic Factor Levels as Potential Risk Factors for Thrombosis. Arch Pathol Lab Med 126:1405-1414, 2002.

113. Flanders, Michele M., Crist, Ronda, and Rodgers, George M.: A Comparison of Five Thrombin Time Reagents. Clin Chem 49:169-172, 2003.

114. Judd, Allan M., Best, Katrina B., Christensen, Katherine, Rodgers, George M., and Bell, John D. Alterations in Susceptibility to Calcium and Enzymatic Hydrolysis of Membranes from Sickle Cell Disease and Trait Erythrocytes. Am J Hematol 72:162-169, 2003.

115. Rodgers, George M.: Improving the Laboratory Diagnosis of Heparin-Induced Thrombocytopenia (Editorial). Am J Med 114:609-610, 2003.

116. Buchanan, Glenn S., Rodgers, George M., and Branch, D. Ware: The Inherited Thrombophilias: Genetics, Epidemiology, and Laboratory Evaluation. Best Practice Res Clin Obstet Gyn 17:397-411, 2003.

117. Branch, D. Ware and Rodgers, George M.: Recombinant Activated Factor VII: A New Weapon in the Fight Against Hemorrhage (Editorial). Obstet Gynecol 101:1155-1156, 2003.

118. Rodgers, George M.: Hereditary Hemorrhagic Telangiectasia. In THE IRON DISORDERS GUIDE TO ANEMIA (Garrison C., Editor) Cumberland House, Nashville, Tennessee, 2003, pp. 361-367.

119. Flanders, Michele M., Crist, Ronda, and Rodgers, George M.: A Comparison of Blood Collection in Glass vs Plastic Vacutainers on Results of Esoteric Coagulation Assays. Laboratory Medicine 34:732-735, 2003.

120. Silverstein, Scott B., and Rodgers, George M.: Parenteral Iron Therapy Options. Am J Hematol, 76:74-78,2004.

121. Shami, Paul J. and Rodgers, George M.: Angiogenesis and Regulation of Hemostasis by Vascular Endothelium. In WINTROBE?S CLINICAL HEMATOLOGY (Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B, Eds.) Lippincott Williams and Wilkins, Philadelphia, 11th edition, 2004, pp. 775-787.

122. Rodgers, George M.: The Diagnostic Approach to the Bleeding Disorders In WINTROBE?S CLINICAL HEMATOLOGY (Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B, Eds.) Lippincott Williams and Wilkins, Philadelphia,11th edition, 2004, pp. 1511-1528.

123. Rees, Matthew M., and Rodgers, George M.: Bleeding Disorders Caused by Vascular Abnormalities. In WINTROBE?S CLINICAL HEMATOLOGY (Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B, Eds.) Lippincott Williams and Wilkins, Philadelphia, 11th edition, 2004, pp. 1573-1589.

124. Friedman, Kenneth D. and Rodgers, George M.: Inherited Coagulation Disorders. In WINTROBE?S CLINICAL HEMATOLOGY (Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B, Eds.) Lippincott Williams and Wilkins, Philadelphia, 11th edition, 2004. pp. 1619-1667.

125. Rodgers, George M.: Acquired Coagulation Disorders. In WINTROBE?S CLINICAL HEMATOLOGY (Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B, Eds.) Lippincott Williams and Wilkins, Philadelphia, 11th edition, 2004, pp. 1669-1712.

126. Deitcher, Steven R. and Rodgers, George M.: Thrombosis and Antithrombotic Therapy. In WINTROBE?S CLINICAL HEMATOLOGY (Greer JP, Foerster J, Lukens J, Paraskevas F, Rodgers GM, Glader B, Eds.) Lippincott Williams and Wilkins, Philadelphia, 11th edition, pp. 1713-1758.

127. Lehman, Chris M., Wilson, Lori W., and Rodgers, George M.: Analytical Validation and Clinical Evaluation of the Utility of the STA LIATEST D-Dimer Assay for the Diagnosis of Disseminated Intravascular Coagulation. Am J Clin Path. 122:178-184, 2004.

128. Terry, Christi M., Kling, Stephen J., Cheang Kai I., Hoidal, John R., and Rodgers, George M.: Polymorphisms in the 5?-Untranslated Region of the Tissue Factor Gene are Associated with Altered Expression in Human Endothelial Cells. J Thromb Haemost. 2:1351-1358, 2004.

129. Flanders, Michele M. and Rodgers, George M. : Evaluation of a New Russell?s Viper-Venom-Based Protein C Assay. Thromb Haemost. 92:430-431, 2004.

130. Yang, David T., Robetorye, Ryan S. and Rodgers, George M.: Home Prothrombin Time Monitoring: A Literature Analysis. Am J Hematol. 77:177-186,2004.

131. Stinnett, Jason M., Pendleton, Robert C., Skordos, Le Ann, Wheeler, Michelle M., and Rodgers, George M.: Venous Thromboembolism Prophylaxis in Medically-Ill Patients and the Development of Strategies to Improve Prophylaxis Rates. Am J Hematol. 78:167-172, 2005.

132. Pendleton, Robert C., Wheeler, Michelle, and Rodgers, George M.: Venous Thromboembolism Prevention in the Acutely-Ill Medical Patient: A Review of the Literature and Focus on Special Patient Populations. Am J. Hematol,. 79:229-237, 2005.

133. Flanders, Michele M., Crist, Ronda, Roberts, William, and Rodgers, George M.: Pediatric Reference Intervals for Seven Common Coagulation Assays. Clin Chem 51:1738-1742, 2005.

134. Laman, Christopher A., Silverstein, Scott B., and Rodgers, George M.: Parenteral Iron Therapy: A Single Institution?s Experience Over a 5-year Period. J Natl Compr Canc Netw 3:791-795, 2005.

135. Rodgers GM, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Demitri GD, Djulbegovic B, Garst JL, Gore M, Kraut EH, Lin WC, Millenson M, Mock V, Reinke D, Rosenthal J, Sabbatini P. Cancer and Treatment-Related Anemia. J Natl Compr Canc Netw 3:772-789, 2005.

136. Rodgers, George M.: Bleeding Disorders, Thrombotic Disorders, and Anticoagulant Therapy. Chapters 26-34. In PRACTICAL DIAGNOSIS OF HEMATOLOGIC DISORDERS (Kjeldsberg, C., Eds.) ASCP Press, Chicago, Fourth edition, 2006.

137. Agarwal, Neeraj, Spahr, Joseph, Werner, Theresa L., Newton, David and Rodgers, George M.: Acquired Amegakaryocytic Thrombocytopenic Purpura. Am J Hematol. 81:132-135, 2006.

138. Pendleton, Robert C., Wheeler, Michelle M., and Rodgers, George M.: Argatroban Dosing of Patients with Heparin-Induced Thrombocytopenia and an Elevated Baseline APTT. Ann Pharmacotherapy. 40:972-976, 2006.

139. Rodgers, George M. Guidelines for the Use of Erythropoietic Growth Factors in Patients with Chemotherapy-Induced Anemia. Oncology. 2006; 20 (Suppl 6):12-15.

140. Kling, Stephen J., Griffee, Matthew, Flanders, Michele M., and Rodgers, George M. Factor V Deficiency Caused by a Novel Missense Mutation, Ile417Thr, in the A2 Domain: Factor V Ogden. J Thromb Haemost. 4:481-483, 2006.

141. Yang, David T., Flanders, Michele M., Kim, Hyunhee, and Rodgers, George M.: Increased Risk of Cerebrovascular Events is Associated with Elevated Factor XI Activity. Am J Clin Pathol. 126:411?415, 2006.

142. Flanders, Michele M., Crist, Ronda A., Phansalkar, Amit R., Roberts, William L., and Rodgers, George M.: Pediatric Reference Intervals for Uncommon Bleeding and Thrombotic Disorders. J Pediatrics. 149:275-277, 2006.

143. Pendleton, Robert C. and Rodgers, George M.: Diagnostic Dilemma: A Necessary Detour. Am J Med. 119:651-653, 2006.

144. Rondina, Matthew T., Pendleton, Robert C., Wheeler, Michelle, and Rodgers, George M.: The Treatment of Venous Thromboembolism in Special Populations. Thromb Res. 119:391?402, 2007.

145. Spahr, Joseph E., Maul, J. Scott, and Rodgers, George M.: Superwarfarin Poisoning: A Report of Two Cases and Review of the Literature. Am J Hematol. 82:656?660, 2007.

146. Werner, Theresa L, Agarwal, Neeraj, Carney, Heather, and Rodgers, George M.: Management of Cancer-associated Thrombotic Microangiopathy: What is the Right Approach? Am J Hematol. 82:295?298, 2007.

147. Kling, Stephen J., Jones, Kimberly A., and Rodgers, George M.: A Second Case of Prothrombin Puerto Rico I in the United States. Am J Hematol. 82:661?662, 2007.

148. Agarwal, Neeraj, Spahr, Joseph E., and Rodgers, George M.: Successful Management of Intra-abdominal Hemorrhage in the Presence of Severe Alcoholic Liver Disease with Activated Recombinant Factor VII (rFVIIa; Novo-Seven). A Case Report and Review of the Literature on Approved and Off-label Use of rVIIa. Blood Coag Fibrinol. 18:205?207, 2007.

149. Bennett, Sterling, Lehman, Christopher M., and Rodgers, George M. LABORATORY HEMOSTASIS: A PRACTICAL GUIDE FOR PATHOLOGISTS. Springer, New York, 2007.

150. Rondina, Matthew T., Markewitz, Boaz, Kling, Stephen J., Nohavec, Robert, and Rodgers, George M.: Accuracy of Activated Partial Thromboplastin Times when Drawn Through a Peripherally Inserted Central Catheter. Am J Hematol. 82:738?739, 2007.

151. Tandar, Anwar, Lehman, Christopher M., Rodgers, George M., Meredith, Kent G., Muhlestein, Joseph B., Barry, William H., Michaels, Andrew D., and Lee, Howard R.: Activation of Coagulation During Routine Coronary Angiography. EuroIntervention, 3:345?349, 2007.

152. Spahr, Joseph E. and Rodgers, George M.: Treatment of Immune-Mediated Thrombocytopenia Purpura with concurrent Intravenous Immunoglobulin and Platelet Transfusion: A Retrospective Review of 40 Patients. Am J Hematol, 83:122?125, 2008.

153. Yaish, Hassan and Rodgers, George M.: A Hemophilia B Patient with Severe Burn Injury: Increased Requirement for Factor IX Replacement Therapy. Haemophilia, 14:607?609, 2008.

154. Rodgers, George M. Anemia. In SUPPORTIVE CARE IN CANCER THERAPY (Ettinger, DS, Ed) Humana Press, 2009, pp. 153-163.

155. Jackson, Brian R., Holmes, Kyland, Phansalkar, Amit R., and Rodgers, George M.: Testing for Hereditary Thrombophilia: A Retrospective Analysis of Testing Referred to a National Laborator